Dapoxetine licensed as Priligy

It’s been a long road, but men are finally going to be able to get Johnson & Johnson’s premature ejaculation drug dapoxetine — at least in Sweden and Finland.

J&J’s Janssen-Cilag unit announced today that the two Nordic countries have greenlighted the medicine, which has been newly christened Priligy. A member of the same group of drugs as Prozac, the medicine bounced from Eli Lilly to a contract organization called PPD before finding a home at J&J in 2001.

In the eight years since then, J&J has pumped out study after study showing that men on dapoxetine were able to delay orgasm for a couple minutes longer than on placebo. But the FDA flatly rejected the medicine in 2005. The reasons for the FDA snub are under wraps, but it came around the same time as the debate about antidepressants and suicidality was raging.

J&J is still deciding whether it will ask for the drug to be reconsidered in the U.S. Meantime, it will launch in April in Sweden and Finland, and J&J is expecting word soon on Austria, Germany, Spain, Italy and Portugal.

DRM will be offering Dapoxetine as soon as this treatment becomes available.

Subscribe to our Newsletter and we will notify you when you can order Dapoxetine online.

PRILIGY / DAPOXETINE - MORE INFORMATION